img

Global Generic Drug Intermediates CDMO Services Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Generic Drug Intermediates CDMO Services Market Insights, Forecast to 2034

Generic Drug Intermediates CDMO (Contract Development and Manufacturing Organization) Services refer to the outsourcing of research, development, and manufacturing processes related to the production of generic drug intermediates. CDMOs specialize in providing comprehensive services such as process development, optimization, scale-up, and commercial manufacturing of intermediates for generic drugs. These services include synthesis of key chemical compounds and intermediates that are essential in the production of generic pharmaceutical products. Generic Drug Intermediates CDMO Services offer pharmaceutical companies a cost-effective and efficient solution for the development and manufacturing of generic drugs, helping them meet regulatory requirements and bring quality, affordable medications to the market.
Market Analysis and InsightsGlobal Generic Drug Intermediates CDMO Services Market
Global Generic Drug Intermediates CDMO Services market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Generic Drug Intermediates CDMO Services industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
The market prospects for Generic Drug Intermediates CDMO (Contract Development Manufacturing Organization) Services are expected to be strong. The demand for generic drugs continues to rise due to their cost-effectiveness and increasing focus on accessible healthcare. Generic drug manufacturers often seek specialized services from CDMOs for efficient and streamlined processes in the development and manufacturing of drug intermediates. CDMOs offer expertise, regulatory compliance, and cost-effective manufacturing solutions. As the pharmaceutical industry strives to meet the growing demand for generic drugs, the market for Generic Drug Intermediates CDMO Services is projected to expand, providing pharmaceutical companies with essential support to deliver high-quality and affordable medications.
Report Covers
This report presents an overview of global Generic Drug Intermediates CDMO Services market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Generic Drug Intermediates CDMO Services market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Euroapi
Cambrex
Recipharm
Thermo Fisher Scientific
Wuxi New Drug Development
Pharmaron Beijing
Asymchem Laboratories
Porton Pharma Solutions
ChengDa Pharmaceuticals
Segment by Type
Process Optimization of Generic Intermediates
Production of Generic Intermediates

Segment by Application


Pharmaceutical Enterprise
Laboratory
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Generic Drug Intermediates CDMO Services introduction, etc. Generic Drug Intermediates CDMO Services Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Generic Drug Intermediates CDMO Services
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Generic Drug Intermediates CDMO Services Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Process Optimization of Generic Intermediates
1.2.3 Production of Generic Intermediates
1.3 Market by Application
1.3.1 Global Generic Drug Intermediates CDMO Services Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Pharmaceutical Enterprise
1.3.3 Laboratory
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Generic Drug Intermediates CDMO Services Market Perspective (2018-2033)
2.2 Global Generic Drug Intermediates CDMO Services Growth Trends by Region
2.2.1 Generic Drug Intermediates CDMO Services Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Generic Drug Intermediates CDMO Services Historic Market Size by Region (2018-2023)
2.2.3 Generic Drug Intermediates CDMO Services Forecasted Market Size by Region (2024-2033)
2.3 Generic Drug Intermediates CDMO Services Market Dynamics
2.3.1 Generic Drug Intermediates CDMO Services Industry Trends
2.3.2 Generic Drug Intermediates CDMO Services Market Drivers
2.3.3 Generic Drug Intermediates CDMO Services Market Challenges
2.3.4 Generic Drug Intermediates CDMO Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Generic Drug Intermediates CDMO Services by Players
3.1.1 Global Generic Drug Intermediates CDMO Services Revenue by Players (2018-2023)
3.1.2 Global Generic Drug Intermediates CDMO Services Revenue Market Share by Players (2018-2023)
3.2 Global Generic Drug Intermediates CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Generic Drug Intermediates CDMO Services, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Generic Drug Intermediates CDMO Services Market Concentration Ratio
3.4.1 Global Generic Drug Intermediates CDMO Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Generic Drug Intermediates CDMO Services Revenue in 2022
3.5 Global Key Players of Generic Drug Intermediates CDMO Services Head office and Area Served
3.6 Global Key Players of Generic Drug Intermediates CDMO Services, Product and Application
3.7 Global Key Players of Generic Drug Intermediates CDMO Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Generic Drug Intermediates CDMO Services Breakdown Data by Type
4.1 Global Generic Drug Intermediates CDMO Services Historic Market Size by Type (2018-2023)
4.2 Global Generic Drug Intermediates CDMO Services Forecasted Market Size by Type (2024-2033)
5 Generic Drug Intermediates CDMO Services Breakdown Data by Application
5.1 Global Generic Drug Intermediates CDMO Services Historic Market Size by Application (2018-2023)
5.2 Global Generic Drug Intermediates CDMO Services Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Generic Drug Intermediates CDMO Services Market Size (2018-2033)
6.2 North America Generic Drug Intermediates CDMO Services Market Size by Type
6.2.1 North America Generic Drug Intermediates CDMO Services Market Size by Type (2018-2023)
6.2.2 North America Generic Drug Intermediates CDMO Services Market Size by Type (2024-2033)
6.2.3 North America Generic Drug Intermediates CDMO Services Market Share by Type (2018-2033)
6.3 North America Generic Drug Intermediates CDMO Services Market Size by Application
6.3.1 North America Generic Drug Intermediates CDMO Services Market Size by Application (2018-2023)
6.3.2 North America Generic Drug Intermediates CDMO Services Market Size by Application (2024-2033)
6.3.3 North America Generic Drug Intermediates CDMO Services Market Share by Application (2018-2033)
6.4 North America Generic Drug Intermediates CDMO Services Market Size by Country
6.4.1 North America Generic Drug Intermediates CDMO Services Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Generic Drug Intermediates CDMO Services Market Size by Country (2018-2023)
6.4.3 North America Generic Drug Intermediates CDMO Services Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Generic Drug Intermediates CDMO Services Market Size (2018-2033)
7.2 Europe Generic Drug Intermediates CDMO Services Market Size by Type
7.2.1 Europe Generic Drug Intermediates CDMO Services Market Size by Type (2018-2023)
7.2.2 Europe Generic Drug Intermediates CDMO Services Market Size by Type (2024-2033)
7.2.3 Europe Generic Drug Intermediates CDMO Services Market Share by Type (2018-2033)
7.3 Europe Generic Drug Intermediates CDMO Services Market Size by Application
7.3.1 Europe Generic Drug Intermediates CDMO Services Market Size by Application (2018-2023)
7.3.2 Europe Generic Drug Intermediates CDMO Services Market Size by Application (2024-2033)
7.3.3 Europe Generic Drug Intermediates CDMO Services Market Share by Application (2018-2033)
7.4 Europe Generic Drug Intermediates CDMO Services Market Size by Country
7.4.1 Europe Generic Drug Intermediates CDMO Services Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Generic Drug Intermediates CDMO Services Market Size by Country (2018-2023)
7.4.3 Europe Generic Drug Intermediates CDMO Services Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Generic Drug Intermediates CDMO Services Market Size (2018-2033)
8.2 China Generic Drug Intermediates CDMO Services Market Size by Type
8.2.1 China Generic Drug Intermediates CDMO Services Market Size by Type (2018-2023)
8.2.2 China Generic Drug Intermediates CDMO Services Market Size by Type (2024-2033)
8.2.3 China Generic Drug Intermediates CDMO Services Market Share by Type (2018-2033)
8.3 China Generic Drug Intermediates CDMO Services Market Size by Application
8.3.1 China Generic Drug Intermediates CDMO Services Market Size by Application (2018-2023)
8.3.2 China Generic Drug Intermediates CDMO Services Market Size by Application (2024-2033)
8.3.3 China Generic Drug Intermediates CDMO Services Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Generic Drug Intermediates CDMO Services Market Size (2018-2033)
9.2 Asia Generic Drug Intermediates CDMO Services Market Size by Type
9.2.1 Asia Generic Drug Intermediates CDMO Services Market Size by Type (2018-2023)
9.2.2 Asia Generic Drug Intermediates CDMO Services Market Size by Type (2024-2033)
9.2.3 Asia Generic Drug Intermediates CDMO Services Market Share by Type (2018-2033)
9.3 Asia Generic Drug Intermediates CDMO Services Market Size by Application
9.3.1 Asia Generic Drug Intermediates CDMO Services Market Size by Application (2018-2023)
9.3.2 Asia Generic Drug Intermediates CDMO Services Market Size by Application (2024-2033)
9.3.3 Asia Generic Drug Intermediates CDMO Services Market Share by Application (2018-2033)
9.4 Asia Generic Drug Intermediates CDMO Services Market Size by Region
9.4.1 Asia Generic Drug Intermediates CDMO Services Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Generic Drug Intermediates CDMO Services Market Size by Region (2018-2023)
9.4.3 Asia Generic Drug Intermediates CDMO Services Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Generic Drug Intermediates CDMO Services Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Generic Drug Intermediates CDMO Services Market Size by Type
10.2.1 Middle East, Africa, and Latin America Generic Drug Intermediates CDMO Services Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Generic Drug Intermediates CDMO Services Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Generic Drug Intermediates CDMO Services Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Generic Drug Intermediates CDMO Services Market Size by Application
10.3.1 Middle East, Africa, and Latin America Generic Drug Intermediates CDMO Services Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Generic Drug Intermediates CDMO Services Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Generic Drug Intermediates CDMO Services Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Generic Drug Intermediates CDMO Services Market Size by Country
10.4.1 Middle East, Africa, and Latin America Generic Drug Intermediates CDMO Services Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Generic Drug Intermediates CDMO Services Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Generic Drug Intermediates CDMO Services Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Euroapi
11.1.1 Euroapi Company Details
11.1.2 Euroapi Business Overview
11.1.3 Euroapi Generic Drug Intermediates CDMO Services Introduction
11.1.4 Euroapi Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023)
11.1.5 Euroapi Recent Developments
11.2 Cambrex
11.2.1 Cambrex Company Details
11.2.2 Cambrex Business Overview
11.2.3 Cambrex Generic Drug Intermediates CDMO Services Introduction
11.2.4 Cambrex Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023)
11.2.5 Cambrex Recent Developments
11.3 Recipharm
11.3.1 Recipharm Company Details
11.3.2 Recipharm Business Overview
11.3.3 Recipharm Generic Drug Intermediates CDMO Services Introduction
11.3.4 Recipharm Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023)
11.3.5 Recipharm Recent Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Generic Drug Intermediates CDMO Services Introduction
11.4.4 Thermo Fisher Scientific Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023)
11.4.5 Thermo Fisher Scientific Recent Developments
11.5 Wuxi New Drug Development
11.5.1 Wuxi New Drug Development Company Details
11.5.2 Wuxi New Drug Development Business Overview
11.5.3 Wuxi New Drug Development Generic Drug Intermediates CDMO Services Introduction
11.5.4 Wuxi New Drug Development Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023)
11.5.5 Wuxi New Drug Development Recent Developments
11.6 Pharmaron Beijing
11.6.1 Pharmaron Beijing Company Details
11.6.2 Pharmaron Beijing Business Overview
11.6.3 Pharmaron Beijing Generic Drug Intermediates CDMO Services Introduction
11.6.4 Pharmaron Beijing Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023)
11.6.5 Pharmaron Beijing Recent Developments
11.7 Asymchem Laboratories
11.7.1 Asymchem Laboratories Company Details
11.7.2 Asymchem Laboratories Business Overview
11.7.3 Asymchem Laboratories Generic Drug Intermediates CDMO Services Introduction
11.7.4 Asymchem Laboratories Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023)
11.7.5 Asymchem Laboratories Recent Developments
11.8 Porton Pharma Solutions
11.8.1 Porton Pharma Solutions Company Details
11.8.2 Porton Pharma Solutions Business Overview
11.8.3 Porton Pharma Solutions Generic Drug Intermediates CDMO Services Introduction
11.8.4 Porton Pharma Solutions Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023)
11.8.5 Porton Pharma Solutions Recent Developments
11.9 ChengDa Pharmaceuticals
11.9.1 ChengDa Pharmaceuticals Company Details
11.9.2 ChengDa Pharmaceuticals Business Overview
11.9.3 ChengDa Pharmaceuticals Generic Drug Intermediates CDMO Services Introduction
11.9.4 ChengDa Pharmaceuticals Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023)
11.9.5 ChengDa Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Generic Drug Intermediates CDMO Services Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Process Optimization of Generic Intermediates
Table 3. Key Players of Production of Generic Intermediates
Table 4. Global Generic Drug Intermediates CDMO Services Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 5. Global Generic Drug Intermediates CDMO Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Generic Drug Intermediates CDMO Services Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Generic Drug Intermediates CDMO Services Market Share by Region (2018-2023)
Table 8. Global Generic Drug Intermediates CDMO Services Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Generic Drug Intermediates CDMO Services Market Share by Region (2024-2033)
Table 10. Generic Drug Intermediates CDMO Services Market Trends
Table 11. Generic Drug Intermediates CDMO Services Market Drivers
Table 12. Generic Drug Intermediates CDMO Services Market Challenges
Table 13. Generic Drug Intermediates CDMO Services Market Restraints
Table 14. Global Generic Drug Intermediates CDMO Services Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Generic Drug Intermediates CDMO Services Revenue Share by Players (2018-2023)
Table 16. Global Top Generic Drug Intermediates CDMO Services by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Drug Intermediates CDMO Services as of 2022)
Table 17. Global Generic Drug Intermediates CDMO Services Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Generic Drug Intermediates CDMO Services Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Generic Drug Intermediates CDMO Services, Headquarters and Area Served
Table 20. Global Key Players of Generic Drug Intermediates CDMO Services, Product and Application
Table 21. Global Key Players of Generic Drug Intermediates CDMO Services, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Generic Drug Intermediates CDMO Services Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Generic Drug Intermediates CDMO Services Revenue Market Share by Type (2018-2023)
Table 25. Global Generic Drug Intermediates CDMO Services Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Generic Drug Intermediates CDMO Services Revenue Market Share by Type (2024-2033)
Table 27. Global Generic Drug Intermediates CDMO Services Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Generic Drug Intermediates CDMO Services Revenue Share by Application (2018-2023)
Table 29. Global Generic Drug Intermediates CDMO Services Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Generic Drug Intermediates CDMO Services Revenue Share by Application (2024-2033)
Table 31. North America Generic Drug Intermediates CDMO Services Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Generic Drug Intermediates CDMO Services Market Size by Type (2024-2033) & (US$ Million)
Table 33. North America Generic Drug Intermediates CDMO Services Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Generic Drug Intermediates CDMO Services Market Size by Application (2024-2033) & (US$ Million)
Table 35. North America Generic Drug Intermediates CDMO Services Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Generic Drug Intermediates CDMO Services Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Generic Drug Intermediates CDMO Services Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Generic Drug Intermediates CDMO Services Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Generic Drug Intermediates CDMO Services Market Size by Type (2024-2033) & (US$ Million)
Table 40. Europe Generic Drug Intermediates CDMO Services Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Generic Drug Intermediates CDMO Services Market Size by Application (2024-2033) & (US$ Million)
Table 42. Europe Generic Drug Intermediates CDMO Services Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe Generic Drug Intermediates CDMO Services Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Generic Drug Intermediates CDMO Services Market Size by Country (2024-2033) & (US$ Million)
Table 45. China Generic Drug Intermediates CDMO Services Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Generic Drug Intermediates CDMO Services Market Size by Type (2024-2033) & (US$ Million)
Table 47. China Generic Drug Intermediates CDMO Services Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Generic Drug Intermediates CDMO Services Market Size by Application (2024-2033) & (US$ Million)
Table 49. Asia Generic Drug Intermediates CDMO Services Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Generic Drug Intermediates CDMO Services Market Size by Type (2024-2033) & (US$ Million)
Table 51. Asia Generic Drug Intermediates CDMO Services Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Generic Drug Intermediates CDMO Services Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia Generic Drug Intermediates CDMO Services Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 54. Asia Generic Drug Intermediates CDMO Services Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Generic Drug Intermediates CDMO Services Market Size by Region (2024-2033) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Generic Drug Intermediates CDMO Services Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Generic Drug Intermediates CDMO Services Market Size by Type (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Generic Drug Intermediates CDMO Services Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Generic Drug Intermediates CDMO Services Market Size by Application (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Generic Drug Intermediates CDMO Services Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 61. Middle East, Africa, and Latin America Generic Drug Intermediates CDMO Services Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Generic Drug Intermediates CDMO Services Market Size by Country (2024-2033) & (US$ Million)
Table 63. Euroapi Company Details
Table 64. Euroapi Business Overview
Table 65. Euroapi Generic Drug Intermediates CDMO Services Product
Table 66. Euroapi Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023) & (US$ Million)
Table 67. Euroapi Recent Developments
Table 68. Cambrex Company Details
Table 69. Cambrex Business Overview
Table 70. Cambrex Generic Drug Intermediates CDMO Services Product
Table 71. Cambrex Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023) & (US$ Million)
Table 72. Cambrex Recent Developments
Table 73. Recipharm Company Details
Table 74. Recipharm Business Overview
Table 75. Recipharm Generic Drug Intermediates CDMO Services Product
Table 76. Recipharm Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023) & (US$ Million)
Table 77. Recipharm Recent Developments
Table 78. Thermo Fisher Scientific Company Details
Table 79. Thermo Fisher Scientific Business Overview
Table 80. Thermo Fisher Scientific Generic Drug Intermediates CDMO Services Product
Table 81. Thermo Fisher Scientific Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023) & (US$ Million)
Table 82. Thermo Fisher Scientific Recent Developments
Table 83. Wuxi New Drug Development Company Details
Table 84. Wuxi New Drug Development Business Overview
Table 85. Wuxi New Drug Development Generic Drug Intermediates CDMO Services Product
Table 86. Wuxi New Drug Development Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023) & (US$ Million)
Table 87. Wuxi New Drug Development Recent Developments
Table 88. Pharmaron Beijing Company Details
Table 89. Pharmaron Beijing Business Overview
Table 90. Pharmaron Beijing Generic Drug Intermediates CDMO Services Product
Table 91. Pharmaron Beijing Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023) & (US$ Million)
Table 92. Pharmaron Beijing Recent Developments
Table 93. Asymchem Laboratories Company Details
Table 94. Asymchem Laboratories Business Overview
Table 95. Asymchem Laboratories Generic Drug Intermediates CDMO Services Product
Table 96. Asymchem Laboratories Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023) & (US$ Million)
Table 97. Asymchem Laboratories Recent Developments
Table 98. Porton Pharma Solutions Company Details
Table 99. Porton Pharma Solutions Business Overview
Table 100. Porton Pharma Solutions Generic Drug Intermediates CDMO Services Product
Table 101. Porton Pharma Solutions Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023) & (US$ Million)
Table 102. Porton Pharma Solutions Recent Developments
Table 103. ChengDa Pharmaceuticals Company Details
Table 104. ChengDa Pharmaceuticals Business Overview
Table 105. ChengDa Pharmaceuticals Generic Drug Intermediates CDMO Services Product
Table 106. ChengDa Pharmaceuticals Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023) & (US$ Million)
Table 107. ChengDa Pharmaceuticals Recent Developments
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Generic Drug Intermediates CDMO Services Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Generic Drug Intermediates CDMO Services Market Share by Type: 2022 VS 2033
Figure 3. Process Optimization of Generic Intermediates Features
Figure 4. Production of Generic Intermediates Features
Figure 5. Global Generic Drug Intermediates CDMO Services Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 6. Global Generic Drug Intermediates CDMO Services Market Share by Application: 2022 VS 2033
Figure 7. Pharmaceutical Enterprise Case Studies
Figure 8. Laboratory Case Studies
Figure 9. Other Case Studies
Figure 10. Generic Drug Intermediates CDMO Services Report Years Considered
Figure 11. Global Generic Drug Intermediates CDMO Services Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Generic Drug Intermediates CDMO Services Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Generic Drug Intermediates CDMO Services Market Share by Region: 2022 VS 2033
Figure 14. Global Generic Drug Intermediates CDMO Services Market Share by Players in 2022
Figure 15. Global Top Generic Drug Intermediates CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Drug Intermediates CDMO Services as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Generic Drug Intermediates CDMO Services Revenue in 2022
Figure 17. North America Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Generic Drug Intermediates CDMO Services Market Share by Type (2018-2033)
Figure 19. North America Generic Drug Intermediates CDMO Services Market Share by Application (2018-2033)
Figure 20. North America Generic Drug Intermediates CDMO Services Market Share by Country (2018-2033)
Figure 21. United States Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Generic Drug Intermediates CDMO Services Market Size YoY (2018-2033) & (US$ Million)
Figure 24. Europe Generic Drug Intermediates CDMO Services Market Share by Type (2018-2033)
Figure 25. Europe Generic Drug Intermediates CDMO Services Market Share by Application (2018-2033)
Figure 26. Europe Generic Drug Intermediates CDMO Services Market Share by Country (2018-2033)
Figure 27. Germany Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. China Generic Drug Intermediates CDMO Services Market Size YoY (2018-2033) & (US$ Million)
Figure 34. China Generic Drug Intermediates CDMO Services Market Share by Type (2018-2033)
Figure 35. China Generic Drug Intermediates CDMO Services Market Share by Application (2018-2033)
Figure 36. Asia Generic Drug Intermediates CDMO Services Market Size YoY (2018-2033) & (US$ Million)
Figure 37. Asia Generic Drug Intermediates CDMO Services Market Share by Type (2018-2033)
Figure 38. Asia Generic Drug Intermediates CDMO Services Market Share by Application (2018-2033)
Figure 39. Asia Generic Drug Intermediates CDMO Services Market Share by Region (2018-2033)
Figure 40. Japan Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. South Korea Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. China Taiwan Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Southeast Asia Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. India Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Australia Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Generic Drug Intermediates CDMO Services Market Size YoY (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Generic Drug Intermediates CDMO Services Market Share by Type (2018-2033)
Figure 48. Middle East, Africa, and Latin America Generic Drug Intermediates CDMO Services Market Share by Application (2018-2033)
Figure 49. Middle East, Africa, and Latin America Generic Drug Intermediates CDMO Services Market Share by Country (2018-2033)
Figure 50. Brazil Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Mexico Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Turkey Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Israel Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. GCC Countries Generic Drug Intermediates CDMO Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Euroapi Revenue Growth Rate in Generic Drug Intermediates CDMO Services Business (2018-2023)
Figure 57. Cambrex Revenue Growth Rate in Generic Drug Intermediates CDMO Services Business (2018-2023)
Figure 58. Recipharm Revenue Growth Rate in Generic Drug Intermediates CDMO Services Business (2018-2023)
Figure 59. Thermo Fisher Scientific Revenue Growth Rate in Generic Drug Intermediates CDMO Services Business (2018-2023)
Figure 60. Wuxi New Drug Development Revenue Growth Rate in Generic Drug Intermediates CDMO Services Business (2018-2023)
Figure 61. Pharmaron Beijing Revenue Growth Rate in Generic Drug Intermediates CDMO Services Business (2018-2023)
Figure 62. Asymchem Laboratories Revenue Growth Rate in Generic Drug Intermediates CDMO Services Business (2018-2023)
Figure 63. Porton Pharma Solutions Revenue Growth Rate in Generic Drug Intermediates CDMO Services Business (2018-2023)
Figure 64. ChengDa Pharmaceuticals Revenue Growth Rate in Generic Drug Intermediates CDMO Services Business (2018-2023)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries